Representative Christopher H. Smith of New Jersey wrote a letter to the National Institute of Health’s National Institute for Allergies and Infectious Disease Director Dr. Anthony Fauci and Department of Health and Human Services Secretary Alex Azar with the Health and Human Human Services (HHS), dated April 9, 2020.
While Rep. Smith thanks Fauci and Azar for their tireless work on COVID-19, he brings important attention to his concern about ” … the countless individuals who live in this region who also suffer from Lyme Disease.”
Smith stresses his worry for how the virus may impact those with Lyme, stating “I remain deeply concerned about what impact COVID-19 and the Coronavirus outbreak will have on the countless Americans suffering from Lyme Disease and other related coinfections.”
Click here to read the entire letter.
COVID-19 and Lyme Disease Resources from GLA:
GLA POV: Parallel Pandemics: COVID-19 and Lyme Disease
Blog: Q&A on COVID-19 and Lyme Disease with LLMD
Blog: Personal Patient Experience with COVID-19 and Lyme Disease
Letter: GLA CEO Addresses COVID-19 and GLA Community
Letter: GLA Chairman on What We Can Learn from COVID-19 Response